Background/Aim. Intramyocardial bone marrow mononuclear cells (BMMNC) implantation
concomitant to coronary artery bypass grafting (CABG) surgery as an option for regenerative …

Cardiovascular disease is the leading cause of morbidity and mortality in the world. In recent
years, there has been an increasing interest both in basic and clinical research regarding …

There is a growing interest in the clinical application of stem cells as a novel therapeutic
approach for treatment of myocardial infarction and prevention of subsequent heart failure …

There exists a variety of interval estimators for the overall treatment effect in a random‐
effects meta‐analysis. A recent literature review summarizing existing methods suggested …

Cell‐based therapy has emerged as a promising therapy for cardiovascular disease.
Particularly, bone marrow (BM)‐derived cells have been most extensively investigated and …

OBJECTIVES We present here a sub-study of our prospective, randomized, double-blinded
trial of bone marrow mononuclear cell (BMMC) transplantation with coronary artery bypass …

Abstract Coronary Artery Diseases (CAD) is the first mortality cause in industrialized
countries. The possibility of regenerating myocardium injured tissue using the cell therapy is …

enlarged laterally, and the left anterior descending coronary artery (LAD) and its collateral
branches are identified. After systemic heparinization, the left IMA (LIMA) is skeletonized and …

Incomplete revascularization is associated with worse long-term outcomes. Autologous
bone marrow cells (BMC) have recently been tested in patients with severe coronary artery …

Objectives: This study aimed to investigate the feasibility and effects of intramuscular
injections of autologous bone marrow cells (BMC) combined with off-pump coronary artery …